Pharmaceutical solvents Market to Reach US$ 4.1 Bn in Revenues by 202 Dec 2017 | Page 4

Pharmaceutical Solvent Market Analysis
Global market for Pharmaceutical solvents will expand at a sluggish pace, registering a 3.5%
CAGR (in terms of value) during the forecast period 2016-2026.
Global Market for Pharmaceutical Solvents Projected to Witness Sluggish Growth
A majority of medicines & drugs produced in the world are derived from formulating Active
Pharmaceutical Ingredients (API), and such processes require alcoholic solvents such as ethanol,
isopropanol, propanol and propylene glycol.
Production of pharmaceutical solvents continues to be concentrated in the Asia-Pacific excluding Japan
(APEJ) region as leading API suppliers and drug manufacturers in the world have based their production
units in countries such as South Korea, China and India, among others.
Nevertheless, the production of pharmaceutical solvents in the world continues to be riddled with
challenges emanating from stringent manufacturing regulations imposed by governments. Administration
authorities regulating industrial activities in a region are curbing the production of pharmaceutical
solvents which contain high volumes of inflammable fluids. An alarming rise in the incidences of
casualties reported in pharmaceutical solvent manufacturing plants as well as health risks of being
exposed to volatile liquids present in several pharmaceutical solvents will continue to be a major
challenge for drugmakers in the coming years.
©2015 Future Market Insights, All Rights
Reserved
4